Hologic (HOLX)
(Delayed Data from NSDQ)
$79.81 USD
-0.11 (-0.14%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $79.81 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Price, Consensus and EPS Surprise
HOLX 79.81 -0.11(-0.14%)
Will HOLX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for HOLX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for HOLX
HOLX Launches BustTheMyth Campaign for Breast Health Awareness
QIAGEN's TB Testing Business Gets New Exposure at Global Summit
HOLX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock
GEHC's MIM Software to Aid Radiation Therapy With Its Latest FDA Nod
Will Hologic (HOLX) Beat Estimates Again in Its Next Earnings Report?
Other News for HOLX
Buy Rating Maintained for Hologic Amidst Recovery and Strong Capital Management
Hologic price target raised by $5 at Mizuho, here's why
Assessing Hologic: Insights From 10 Financial Analysts
Meta, Alphabet initiated: Wall Street's top analyst calls
Hologic price target raised by $4 at Evercore ISI, here's why